Home >> Pharmaceuticals >> Food & Beverage >>

Protagonist Therapeutics Inc. - Product Pipeline Review - 2015

Published: Aug-2015 | Format: PDF | Global Markets Direct | Number of pages: 24 | Code: MRS - 35154

Protagonist Therapeutics Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Protagonist Therapeutics Inc. - Product Pipeline Review - 2015’, provides an overview of the Protagonist Therapeutics Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Protagonist Therapeutics Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Protagonist Therapeutics Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Protagonist Therapeutics Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Protagonist Therapeutics Inc.’s pipeline products

Reasons to buy

- Evaluate Protagonist Therapeutics Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Protagonist Therapeutics Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Protagonist Therapeutics Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Protagonist Therapeutics Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Protagonist Therapeutics Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Protagonist Therapeutics Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Protagonist Therapeutics Inc. Snapshot 5
Protagonist Therapeutics Inc. Overview 5
Key Information 5
Key Facts 5
Protagonist Therapeutics Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Protagonist Therapeutics Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Protagonist Therapeutics Inc. - Pipeline Products Glance 10
Protagonist Therapeutics Inc. - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Protagonist Therapeutics Inc. - Drug Profiles 11
Peptide Agonists of Hepcidin for Beta-Thalassemia and Juvenile Hemochromatosis 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
PTG-100 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Synthetic Peptides to Block Nav 1.7 Ion Channel for Neuropathic Pain 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Synthetic Peptides To Inhibit Interleukin-6 for Crohn's Disease and Rheumatoid Arthritis 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Synthetic Peptides to Target IL-23R for Crohn's Disease and Ulcerative colitis 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Protagonist Therapeutics Inc. - Pipeline Analysis 16
Protagonist Therapeutics Inc. - Pipeline Products by Target 16
Protagonist Therapeutics Inc. - Pipeline Products by Route of Administration 17
Protagonist Therapeutics Inc. - Pipeline Products by Molecule Type 18
Protagonist Therapeutics Inc. - Pipeline Products by Mechanism of Action 19
Protagonist Therapeutics Inc. - Recent Pipeline Updates 20
Protagonist Therapeutics Inc. - Dormant Projects 21
Protagonist Therapeutics Inc. - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 23
Disclaimer 24

List of Tables
Protagonist Therapeutics Inc., Key Information 5
Protagonist Therapeutics Inc., Key Facts 5
Protagonist Therapeutics Inc. - Pipeline by Indication, 2015 7
Protagonist Therapeutics Inc. - Pipeline by Stage of Development, 2015 8
Protagonist Therapeutics Inc. - Monotherapy Products in Pipeline, 2015 9
Protagonist Therapeutics Inc. - Preclinical, 2015 10
Protagonist Therapeutics Inc. - Pipeline by Target, 2015 16
Protagonist Therapeutics Inc. - Pipeline by Route of Administration, 2015 17
Protagonist Therapeutics Inc. - Pipeline by Molecule Type, 2015 18
Protagonist Therapeutics Inc. - Pipeline Products by Mechanism of Action, 2015 19
Protagonist Therapeutics Inc. - Recent Pipeline Updates, 2015 20
Protagonist Therapeutics Inc. - Dormant Developmental Projects,2015 21
Protagonist Therapeutics Inc., Subsidiaries 22

List of Figures
Protagonist Therapeutics Inc. - Pipeline by Top 10 Indication, 2015 7
Protagonist Therapeutics Inc. - Pipeline by Top 10 Target, 2015 16
Protagonist Therapeutics Inc. - Pipeline by Top 10 Route of Administration, 2015 17
Protagonist Therapeutics Inc. - Pipeline by Top 10 Molecule Type, 2015 18
Protagonist Therapeutics Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 19

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing